These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28606091)

  • 1. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
    Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
    Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
    Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-β-induced EMT.
    Zhang Y; Li JH; Yuan QG; Cao G; Yang WB
    J Cell Biochem; 2019 Aug; 120(8):13651-13657. PubMed ID: 30945341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
    Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 9. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
    Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
    Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.
    Zhang Y; Zhang L
    J Cell Biochem; 2019 Sep; 120(9):15389-15396. PubMed ID: 31026088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
    Niu Y; Shao Z; Wang H; Yang J; Zhang F; Luo Y; Xu L; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():26112. PubMed ID: 27181092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
    Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TES inhibits colorectal cancer progression through activation of p38.
    Li H; Huang K; Gao L; Wang L; Niu Y; Liu H; Wang Z; Wang L; Wang G; Wang J
    Oncotarget; 2016 Jul; 7(29):45819-45836. PubMed ID: 27323777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LASP2 functions as a potential prognostic factor and therapeutic target in nasopharyngeal carcinoma.
    Yang YT; Nie LM; Wei QF; Li WZ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9416-9422. PubMed ID: 33015783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
    Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
    Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
    Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
    Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
    Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.